Patients who have undergone bone marrow transplantation (BMT) remain immunodeficient for months to years posttransplantation. To evaluate the basic molecular events underlying reconstitution of the humoral immune response, we have performed a detailed nucleotide sequence analysis of VH6 containing rearrangements in circulating B cells from two BM donorlrecipient pairs. Our results show that the third complementarity determining region (CDR3) diversity is much lower early after transplantation, compared with that of the donors, and that the clonal variability remains low for 3 months. Repertoire diversification follows an oligoclonal pattern where B lymphopoiesis appears to occur T IS WELL KNOWN THAT bone marrow (BM) transplant recipients develop a cellular and humoral immune deficiency that can last for months to years after the transplantation. The time required for recovery is prolonged if the patient also develops chronic graft-versus-host disease (GVHD).' It has been suggested that reconstitution of the humoral immune system follows ontogenic de~elopment. The pattern of reconstitution of cellular subsets and serum Igs evoked the question whether the posttransplantation immune deficiency could be explained by restriction in utilization of Ig genes similar to that seen in ontogeny. A number of studies have addressed the question of expression of genes coding for the variable region of the Ig heavy chain (V,) at various time points in ontogeny and in central and peripheral lymphoid tissue. The variable and constant region genes for the human Ig heavy chain are located on chromosome 14q. The diverse repertoire of Ig specificities is obtained through a multi-step process where the initial event is recombination of one of at least 30 diversity (D) genes' to one of six joining (JH) genes9 This D-JH complex is then recombined to one of roughly 100 VH In addition to combinatorial diversity,15 junctional diversity (addition of N and P nucleotide~),".'~ differential association with K or A light chains, and somatic mutation'' contribute to the variability of the Ig repertoire. The human VH genes are divided into seven different families based on nucleotide sequence hom01ogy. in waves up to 6 months posttransplantation. The repertoire among donated marrow cells is not reflected in peripheral blood lymphocytes from the transplanted patients. There is differential D gene utilization among both donor and patient samples, whereas JH gene usage is biased toward Jn4, 5, and 6. One month after transplantation the vast majority of the sequenced clones are functional and contain a high frequency of replacement mutations in the CDRs of the v~6 gene. We conclude that lg gene expression is very restricted early after BM1 and that development of the B-cell repertoire appears to follow a wavelike pattern.
Patients who have undergone bone marrow transplantation (BMT) remain immunodeficient for months to years posttransplantation. To evaluate the basic molecular events underlying reconstitution of the humoral immune response, we have performed a detailed nucleotide sequence analysis of VH6 containing rearrangements in circulating B cells from two BM donorlrecipient pairs. Our results show that the third complementarity determining region (CDR3) diversity is much lower early after transplantation, compared with that of the donors, and that the clonal variability remains low for 3 months. Repertoire diversification follows an oligoclonal pattern where B lymphopoiesis appears to occur T IS WELL KNOWN THAT bone marrow (BM) transplant recipients develop a cellular and humoral immune deficiency that can last for months to years after the transplantation. The time required for recovery is prolonged if the patient also develops chronic graft-versus-host disease (GVHD).' It has been suggested that reconstitution of the humoral immune system follows ontogenic de~elopment. ' The pattern of reconstitution of cellular subsets and serum Igs evoked the question whether the posttransplantation immune deficiency could be explained by restriction in utilization of Ig genes similar to that seen in ontogeny. A number of studies have addressed the question of expression of genes coding for the variable region of the Ig heavy chain (V,) at various time points in ontogeny and in central and peripheral lymphoid tissue. The variable and constant region genes for the human Ig heavy chain are located on chromosome 14q. The diverse repertoire of Ig specificities is obtained through a multi-step process where the initial event is recombination of one of at least 30 diversity (D) genes' to one of six joining (JH) genes9 This D-JH complex is then recombined to one of roughly 100 VH In addition to combinatorial diversity,15 junctional diversity (addition of N and P nucleotide~),".'~ differential association with K or A light chains, and somatic mutation'' contribute to the variability of the Ig repertoire. The human VH genes are divided into seven different families based on nucleotide sequence hom01ogy.l~ The largest family is vH3, which contains 28 gene segments with open reading frame and the smallest is V,6, with one functional gene. 20 Studies on VH gene usage in the fetal repertoire show an overrepresentation of the VH6 family,21.22 although the most frequently expressed family is vH3. Interestingly, vH3 gene family usage in the fetal repertoire is not random but three genes, 2 0~1 , 30p1, and 5 6~1 , are markedly overrepre~ented.'~.'~ The vH3 family also dominates the repertoire among peripheral B lymphocytes from healthy a d~l t s .~~~'~ Among naturally activated lymphocytes, however, the VH6 gene is overrepresented while expression of the vH1 and vH3 gene families is decreased (Davidkova G, Pettersson S, Holmberg D, Lundkvist I: Selective usage of VH-genes in adult human B lymphocyte repertoires. Submitted for publication). Fumoux et al'' have analyzed VH gene family usage in BMT patients and found that vH3 utilization is decreased twofold to threefold, compared with normal adults, and is compensated for by transient overexpression of vH4, vH5, and VH6. This bias in VH gene family usage is most significant 60 days after transplantation, although the pattern is obvious also at 30 and 90 days posttransplantation. It has also been reported that the vH3 genes that characterize the fetal repertoire, 56pl and 2 0~1 , as well as the v H 6 gene are markedly overutilized 2 to 5 months posttransplantation.2n At 21 months after BMT the percentage of B cells that use these genes are still twofold to sixfold higher than in healthy adults."
The importance of the VH6 gene in fetal and neonatal VH gene repertoires, together with the similarities between ontogenic development and the posttransplantation humoral 2796 NASMAN AND LUNDKVIST immune system, have led us to study the developmental program of Ig gene rearrangement post BMT. To gain better insight into the molecular mechanisms underlying repertoire expression posttransplantation, we have collected material before and at several timepoints after BMT and performed a detailed nucleotide sequence analysis of VH6-containing rearrangements. For this purpose we have used the polymerase chain reaction (PCR) technique with VH6-specific and JH consensus primers. The first post BMT sample is taken at 4 weeks, ie, before there is a significant amount of B lymphocytes in the periphery. We have also analyzed samples from the BM donor to be able to evaluate the importance of the repertoire of the donated cells versus that of the microenvironment on reconstitution of the immune system.
MATERIALS AND METHODS

Patients and donors.
Peripheral blood (PBL) samples were derived from two BM recipients. The first (patient l ) was a 50-yearold woman with the diagnosis acute lymphoblastic leukemia of pre-B type (pre-B ALL, LI). The BM donor (donor 1) was an HLAidentical sibling. Patient 1 was in partial remission with 7% to 8% lymphoblasts in the BM 1 week before BMT. The protocol for conditioning of patient I was cyclophosphamide (60 mg/kg/d) for 2 consecutive days (days S and 4 before BMT) followed by total body irradiation with a dose of 10 Gy. The lungs were shielded and received a dose of 9 Gy. After BMT patient I was administered methotrexate and cyclosporin as prophylaxis against GVHD. Cyclosporin treatment was administered for 3 months. Details regarding treatment have previously been published.2" Six days after BMT patient I developed a mild (grade I) acute GVHD manifested as a localized skin rash. Five months after BMT patient 1 developed chronic GVHD that engaged the skin and mouth cavity. Before BMT patient I was negative for cytomegalovirus (CMV), but 2 months after BMT CMV was detected in blood samples by PCR, the infection was asymptomatic. Nine months after BMT patient I is healthy with no relapse. The second recipient (patient 2) was a 44-year-old man with the diagnosis lymphoma (K1 +). The BM donor (donor 2) was an HLA-identical sibling. Patient 2 was in complete remission with no detectable tumor cells in the BM I week before BMT. The protocol for conditioning of patient 2 was as described above. Patient 2 was treated with methotrexate and cyclosporin. No sign of GVHD was seen and the cyclosporin treatment was stopped 4 months after BMT. Patient 15 to 30 minutes on ice and washed twice in cold PBS supplemented with 0.5% BSA, 5 mmol/L EDTA, and 0.01% NaN3 (PBSIBSA). The cells were resuspended in cold PBSlBSA (80 pL/107 cells) and a secondary labeling step was performed with 20 &/IO7 cells of anti-isotypic MACS magnetic microbeads (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany). Cells and beads were incubated together for 15 minutes at +4"C. The cells were separated on a Mini-MACS separation column according to the manufacturer's recommendations and the CDlO' and CDlO-fractions were collected. The negative cell fraction was incubated with RPE conjugated anti-CDIY MoAb, washed, and labeled with anti-isotypic MACS magnetic microbeads as described above. The cells were separated on a Mini-MACS separation column and the CD1 9' and CD I9 fractions were collected. All cell fractions were analyzed in a fluorescence-activated cell sorter (Becton Dickinson FACSort) with the software Lysis II (Becton Dickinson). The number of CDIO', CD19' cells in the pre-B cell enriched sample was 10 times higher than the amount of CDIO-, CD19' cells, and the ratio was reversed in the sample enriched for mature B cells. The lymphocyte fractions enriched for pre-B (CDIO ') and mature B (CDl9+) lymphocytes were frozen as cell pellets at -70°C until genomic DNA preparations were performed.
Prepuration o f genomic DNA. DNA preparations were performed as described by Miller et al.'" Briefly, the cells were dissolved in a TRIS-EDTA buffer and lysed with proteinase K and I % sodium dodecyl sulfate (SDS) in 37°C overnight. Proteins were precipitated with saturated NaCl and chromosomal DNA was recovered from the aqueous phase by ethanol precipitation, and dissolved in 1 X TE (TE: IO mmol/L TRIS-HCI pH 7.6, 1 mmolL EDTA pH 8.0). The concentration and purity of the preparations was determined by measuring the absorbance at 260 and 280 nm (DU-62 Spectrophotometer: Beckman Instruments Inc. Fullerton, CA).
PCK u r d PCR primers. PCR was performed in a total volume of SO pL AmpliTaq I X PCR buffer containing 0.5 to 1 .O pg template DNA, 0.8 pmollL of the VH6 primer. 0.53 pmol/L of the JH1,2,4.5 primer. 0.13 pmol/L of the JJ primer, 0.13 pmol/L of the Jl,6 primer, I O % glycerol, and 2.5 U AmpliTaq (Perkin Elmer. Roche Molecular Systems Inc. Branchburg, NJ). The PCR was performed using a thermal cycler (Techne Ltd, Cambridge, UK) with a cycling program as follows: preheating 1 minute at 94°C; I minute at 94°C.
I minute at 69"C, and 0.5 minute at 72°C for 15 cycles; I minute at 94°C. I minute at 65"C, and 0.5 minute at 72°C for 25 cycles, and finally an elongation step of 5.5 minutes at 72°C. The following PCR primers were used: V,,6: S' CCTCTCACTCACCTGTGCCA 3': JH1,2,4.5:
S' AGGAGACGGTGACCAGGGT 3': JH3: S' GAAGAGACGGTGACCATTGT 3': JH6: 5' AGGAGACGGT-GACCGTGGT 3'.
Cloning und sequencing. The amplified PCR products were subcloned into the pT7-Blue(R) vector according to instructions in the pT7 Blue T-vector Kit (Novagen, Madison, WI) except that electroporation (2.5 kV, 25 mF. and 200 $2. on a Gene Pulser; BioRad, Richmond, CA) was used for transformation. Doublestranded DNA sequencing was performed with a Sequenase Version 2.0 DNA Sequencing Kit as recommended by the manufacturer (United States Biochemical, Cleveland, OH). The sequence reactions were separated on a denaturing 6% acrylamide gel and detected with autoradiography.
Seqrrence unalysis. The D gene reading frames were defined as the first, second, and third frame starting from the first nucleotide in the germline sequence and a functional rearrangement is stated when there is an open reading frame through the CDR3.
RESULTS
Reconstitution of lymphocytes and soluble Ig afer BMT.
Both patients 1 and 2 had normal white blood cell and absolute lymphocyte counts before BMT (Table 1) . After the post BMT nadir, the white blood cell count increased to 2.3 X lo9 and 4.2 X lo9 cells/L, respectively, at 4 weeks and was normal 6 weeks post BMT. Six months after BMT the lymphocyte count was less than half of normal values for patient 1. Serum IgM and IgG levels were somewhat low before, as well as after, BMT for patient l and varied between 0.4 to 0.6 g/L and 4.7 to 9.4 g / L , respectively ( Table  1) . Patient 2 had also rather low serum levels of IgM and IgG levels varied between 6.5 and 11.4 g / L . Before BMT the serum IgA level was well within the normal range for both patients. After transplantation the IgA level decreased. Six months post BMT it was within the normal range for patient 1 but still low for patient 2.
Nucleotide sequence analysis of V&-containing rearrangements. In patient 1 a total of 161 individual clones were analyzed and the complete sequences of the CDR3 regions are presented in Fig 2. The average CDR3 length is similar among the different samples (Table  2) (Fig 2) . In patient 2 a total of 122 individual clones were sequenced and the CDR3 regions were analyzed for functional rearrangements (data not shown). None of the rearrangement events identified in patient 2 were found in patient 1, and vice versa.
The frequency of functional VH6-containing rearrangements in the two donors is 29% to 50% in the BM samples and 39% in the PBL sample. In PBL obtained from patient 1 before BMT 67% of the sequenced clones represent a functional rearrangement, and 4 weeks post BMT, taking both patients together, 75% of the rearrangements are func- 
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Clonal variability. To estimate the degree of diversity in the antibody repertoire we calculated the fraction of unique sequences out of all sequences obtained from each sample, ie, if all individual clones represent unique rearrangement events the clonal variability will be 100%. As shown in Fig  3, the donors have a varied repertoire of rearrangements among BM-derived pre-B and mature B cells, as well as among PBL, with a clonal variability close to or equal to 100%. The clonal variability in patient l before BMT is 43% and the variability decreases to 13% after transplantation. In patient 2 the clonal variability is as low as 4% 4 and 6 weeks post BMT. Seven to 10 weeks post BMT the variability is 20% to 40% and at 3 and 6 months the repertoire in patient 1 is almost as diverse as among the donated cells. However, the variability remains low in patient 2.
Reconstitution of the VH6-containing lg repertoire in patient l appears to follow a wavelike pattern in that one of the sequences, represented in 13 of the 19 clones isolated 4 weeks after BMT, is also present in 11 of 23 clones 6 weeks after BMT (Fig 4A) . In the sample obtained 7 weeks after BMT none of the rearrangements found at 4 and 6 weeks after BMT are present. However, 4 clones at 7 weeks after For personal use only. on October 27, 2017. by guest www.bloodjournal.org From BMT contain a rearrangement also present in 9 clones 10 weeks after BMT and in 1 clone 3 months after BMT. Two clones obtained 3 months post BMT share the same rearrangement as well as 2 clones 6 months after BMT, but these clones are not identical. None of the 8 sequences shown in Fig 4A are present in the donor-derived samples. A similar pattern is seen in patient 2, although none of the rearrangements are found at more than one time point (Fig 4B) . Also in patient 2 there is no overlap between donor and recipient derived sequences.
J, gene usage. In all samples from patient 1 the Cproximal J H genes, JH4, JH5, and JH6, are most frequently used (Fig 5) . In pre-B cells all rearrangements containing BM and peripheral blood (Fig 2) . Before BMT, patient 1 uses only three different D gene segments in the VH6-containing rearrangements. With time after BMT the D gene usage becomes more diverse and is comparable with that of the donor cells 3 months post BMT.
Twenty-two different germline D gene segments were represented in the samples from patient 1. Seven of those were only used in BM-derived cells and out of those Dl, DLR5, DXPI/D5, and DAI/DA4 were found only in pre-B cells. D4 is only used in the BM samples where 23.5% of the pre-B cells and 17.6% of the mature B lymphocytes use this gene. D2119 is used by 17.6% of mature B cells from BM, but is not present in any other sample. DM1 and D21/10 represent two D genes that are rearranged in all samples from the donor and that reappear in the patient at 3 months after BMT. DHQ52 is represented in clones isolated 7 weeks, 10 weeks, and 3 months posttransplantation, but all those rearrangements are nonfunctional. D2, DNI, and DIR2 are frequently used in clones isolated from BM and PBL from the donor as well as in PBL from the recipient. All DNIcontaining rearrangements except one are nonfunctional. The DNI gene is frequently used in pre-B leukemia, adult PBL, and in the neonatal repert~ire.~"'~ The DXP gene family, For personal use only. on October 27, 2017. by guest www.bloodjournal.org From which has been reported to be the most frequently used D gene family in the adult PBL repertoire, is also repre~ented.'*.~~ DIR genes can be identified in 2 rearrangements before BMT, 2 rearrangements 4 weeks after BMT, and 2 rearrangements 6 weeks post BMT. This high frequency of DIR gene family utilization could be due to either the low variability at 4 and 6 weeks post BMT (Fig 3A) or a selection of Bcell clones using the DIR gene in combination with VH6. In a recent report, Moore and Meekw could not demonstrate significant rearrangement to the DIR recombination signal sequences, and they suggest that these GC-rich sequences may be explained by N nucleotide additions rather than DIR utilization. We do not think this can explain our results because DIR sequences are the only D genes possible to identify in the more than 30-bp long CDR3 region isolated at 4 and 6 weeks post BMT, even though the match with reported germline sequences is not absolute.
There are some clones that contain more than one D gene (Fig 2) . In the pre-B cell population S of 17 clones have this type of rearrangement. Two of these clones are functionally rearranged and three clones are nonfunctional. Four to 6 weeks after transplantation three unique rearrangements contain D-D fusions, which all are functional. D-D rearrangements are not common among the other samples and where they are present the majority are nonfunctional.
D gene reading frame (RF). The junctional regions of the functional BM-derived VH6-D-JH rearrangements from patient 1 displayed a bias against D genes translated in RFl (Fig 2) . In pre-B cells none of the D genes were in RF1, but among mature B cells RFI was found in 28.6% of the population. This was accompanied by a decrease in RF2 utilization in mature cells. Interestingly, this pattern is indicated also in the early posttransplantation period. Four and 6 weeks post BMT none of the rearrangements use RFI, but during reconstitution of the lymphocyte repertoire the frequency of D genes in RFI increases. Because of the limited number of unique rearrangements early after BMT, the differential utilization of D gene RFs cannot be statistically confirmed.
In adult PBL, cord blood, and fetal repertoires all three D gene reading frames are used in similar frequency, but independently of VH gene family usage, certain D genes preferentially use a specific RF."."Varade et a14' found that 58% of the VH6-containing rearrangements in spleen from young individuals use RF1.
DISCUSSION
The well-documented overrepresentation of the v~6 gene in the fetal Ig repertoire2'.22 as well as in the post BMT s i t~a t i o n~~.~' led us to perform a more detailed analysis of VH6-containing rearrangements before and at several time points after BMT. Our results show that the repertoire 4 to 10 weeks post BMT displays a limited set of rearrangements (Fig 3) . This is in contrast to results derived from the BM donor samples and 3 to 6 months after BMT where there is a higher degree of variability. The high frequency of functional rearrangements and the high R/S ratios among clones isolated 4 and 6 weeks post BMT (Fig 2 and Table 3 ) indicate that there is a positive selection of VH6-expressing B lymphocytes during early reconstitution of the immune system after BMT.
Another similarity between development of the fetal and the post BMT B-cell repertoire is the frequent use of the DN and DK gene families (Fig 2) . 19 In contrast, the DHQ52 gene and the JH3 gene frequently used in the fetal reperare only sparsely rearranged in our material. Instead, JH gene usage in all our samples is biased toward the C-proximal genes, JH4, JHS, and JH6, (Fig 5 ) , which is the case also in both cord blood and adult peripheral blood reperYamada et al" have described a DNl variant gene, with a CA to TG substitution, that could represent either a polymorphism or a new gene in the DN family. This gene has also been described by Mortari et a14' and they proposed the tentative name DN2. We have also identified this variant of DNl among our samples, but since the DN 1 variant gene always is found in association with the JH6c allele and the DN1 gene in association with the JH6b allele (Fig 2) , we believe that this variant represents a polymorphism rather than a new gene in the DN family.
The CDR3 lengths, as shown in Table 2 , do not vary much between the different sample points and are quite similar to the 12. (Fig 2) . Furthermore, some clones contain more than two P nucleotides. In the suggested mechanism for P nucleotide addition a maximum of two nucleotides are added." Our results may be due to N nucleotides in a palindromic sequence or represent a new mechanism for Ig gene repertoire diversification.
To exclude the possibility that the low variability found 4 and 6 weeks post BMT in patient 1 (Fig 3A) was caused by a bias in the PCR amplification process, we performed a second PCR on the sample material from 6 weeks post BMT followed by nucleotide sequence analysis. In Fig 2, 7 clones represented by clone 1 and 3 of the 8 clones represented by clone 2 origin from the first PCR, whereas the remaining clones were isolated in the second experiment. These 23 clones only represent three unique rearrangement events, one of which is represented in clones originating from both PCR amplifications. These results support the notion that the low t0ire21. 24 
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variability is the result of a restricted repertoire in vivo, although we cannot formally exclude the presence of other, nonamplified, rearrangements. It could be argued that the low clonal variability observed at 4 and 6 weeks post BMT in patient 1 was caused by a contaminating sequence that would be preferentially amplified when the number of B cells is very low. However, these sequences have never previously been isolated in our laboratory and, furthermore, none of the other sequences present at 4 (clone 3 and 5) or 6 (clone 1 and 28) weeks post BMT are found at more than one time point. Therefore, we believe that the rearrangement isolated both 4 and 6 weeks post BMT represents an important clone in the early reconstitution of the Ig repertoire. To further confirm the pattern of oligoclonal diversification of the VH6-containing Ig repertoire we analyzed a second BM recipient.
In patient 2 the clonal variability was even lower at 4 and 6 weeks after BMT (Fig 3B) because only one unique rearrangement was found at each time point.
The limited diversity of the antibody repertoire demonstrated by the low clonal variability early after transplantation (Fig 3) is in concordance with the low Ig concentrations in serum, the reduced numbers of peripheral lymphocytes and impaired polyclonai as well as specific immune responses found in BMT patients (Table l) .' Interestingly, the diversification of the repertoire is obviously not just simple additions of new clones to the existing pool of specificities. Instead it looks more like a dynamic system of appearance and disappearance of consecutive clones (Fig 4A and B) . To our knowledge this type of wavelike diversification of the Ig repertoire has not been described, though there is evidence for a sequential rearrangement of human T-cell receptor V, and V+ genes during ~ntogeny.~' It is not likely that these consecutive clones are derived from activated donor B cells or plasma cells transferred with the BM graft because we do not detect any of these rearrangements in the BM or PBL samples from the donor. It has been shown that secretory Ig levels in saliva peak 2 to 3 weeks after BMT and that these Igs are derived from activated cells from the BM donor.48 The Ig levels thereafter gradually decrease and remain low for around 3 months. When the levels increase again the Igs originate from the reconstituted B-cell compartment. The same pattern was found for Ig levels in serum even though the origin of the antibodies was not ~hown.4~ These findings further support our conclusion that the pattern of Ig gene expression during reconstitution of the B-cell repertoire after BMT is a property of the new immune system developing from graft-derived hematopoetic precursors.
